Need for a paradigm shift: the importance of risk factor reduction therapy in treating patients with cardiovascular disease (Q77709231)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9860367%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

review article

1 reference

title

Need for a paradigm shift: the importance of risk factor reduction therapy in treating patients with cardiovascular disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9860367%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

cardiovascular disease

1 reference

S C Smith

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9860367%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

publication date

1 November 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9860367%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

7 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9860367%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9860367%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

10B

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9860367%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

10T-13T

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9860367%20AND%20SRC:MED&resulttype=core&format=json

Coronary Plaque Disruption

7 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900716-4

A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900716-4

Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900716-4

Molecular bases of the acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900716-4

Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900716-4

Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900716-4

Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): Reduction in atherosclerosis progression and clinical events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900716-4

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900716-4

The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900716-4

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900716-4

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900716-4

Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900716-4

Heart attacks: gone with the century?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900716-4

Low rate of treatment of hypercholesterolemia by cardiologists in patients with suspected and proven coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900716-4

Cigarette smoking, tar yields, and non-fatal myocardial infarction: 14,000 cases and 32,000 controls in the United Kingdom. The International Studies of Infarct Survival (ISIS) Collaborators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900716-4

The human costs of tobacco use (1)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900716-4

The human costs of tobacco use (2)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900716-4

Previous aspirin use may attenuate the severity of the manifestation of acute ischemic syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900716-4

Beta blockade during and after myocardial infarction: an overview of the randomized trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900716-4

Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900716-4

Determinants of dropout rate among hypertensive patients in an urban clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900716-4

A case-management system for coronary risk factor modification after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900716-4

10.1016/S0002-9149(98)00716-4

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9860367%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference